Cargando…
Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases
N-acetylcysteine (NAC) is widely used because of its mucolytic effects, taking part in the therapeutic protocols of cystic fibrosis. NAC is also administered as an antidote in acetaminophen (paracetamol) overdosing. Thanks to its wide antioxidative and anti-inflammatory effects, NAC may also be of b...
Autores principales: | Mokra, Daniela, Mokry, Juraj, Barosova, Romana, Hanusrichterova, Juliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526097/ https://www.ncbi.nlm.nih.gov/pubmed/37760016 http://dx.doi.org/10.3390/antiox12091713 |
Ejemplares similares
-
Effects of Green Tea Polyphenol Epigallocatechin-3-Gallate on Markers of Inflammation and Fibrosis in a Rat Model of Pulmonary Silicosis
por: Adamcakova, Jana, et al.
Publicado: (2023) -
N-Acetylcysteine in Mechanically Ventilated Rats with Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome: The Effect of Intravenous Dose on Oxidative Damage and Inflammation
por: Kolomaznik, Maros, et al.
Publicado: (2021) -
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
por: Mokra, Daniela, et al.
Publicado: (2022) -
Glucocorticoids in the treatment of neonatal meconium aspiration syndrome
por: Mokra, Daniela, et al.
Publicado: (2011) -
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
por: Mokra, Daniela, et al.
Publicado: (2021)